Token/Symbol

SCIA

Type

ERC20

Platform

Ethereum

Accepting

BTC, ETH, LTC, Fiat

Token Count

800,000,000

Price

1 SCI = $0.15

Details
β Analysis
Financial
Reviews (0)
Page Views : 10050

Description
Team
Roadmap
White Paper

Stem Cell Innovations is changing the face of health care by expanding access to stem cell research, development, and treatments around the world using blockchain technology.

Our Vision & Solution

At SCI, we are devoted to the international research, development, and implementation of stem cell therapy. We are also expanding our network with professionals, labs, clinics, hospitals, and nonprofit organizations. Our ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. At SCI, we believe such connections should be convenient and at your fingertips, just as so many other services are in modern society. We imagine a world where each and every person, no matter where they come from, will be able to connect with a Stem Cell Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.

EXPANDING ACCESS TO STEM CELL TREATMENTS
SAFE MEDICAL DATA STORAGE
CONTROLLED ACCESSIBILITY
HIPPA COMPLIANT

Mobile Application

Buying Cord Blood Services
Purchasing Medical Supplies
Acquiring Synthetic Stem Cells(discounted, which could save up to 70% of market price)
Paying online app annual memebership fees for professionals (doctors) and discounted memberships for medical students.
Contact Stem CEll Consultant Specialists 24/7
Conducting DNA Enthnicity Tests

Token Distribution

SCI’s goal is to raise a maximum of $36,000,000 and a minimum of $3,000,000. Some of these numbers may change with ETH/ USD exchange rates and volatility throughout the ICO and launch phase of the company’s growth. This document is based on exchange rate estimates at the time of writing. SCI will mint a total of 800 million tokens. Of these, 240 million tokens will be available during the token sale to start on September 17th, 2018.

Each token will be sold at $0.15. Should all 240 million tokens be sold, the raised funds will be $36,000,000. Tokens unsold from the 240 million will be burned. The funds raised during the token sale are to be used per the project roadmap above.

Pre-Sale from 17th September 2018 0800 HRS UTC/GMT to 9th October 2018 2359 HRS UTC/GMT. Main-Sale from 21st November 2018 0800 HRS UTC/GMT to 17th Janurary 2019 2359 HRS UTC/GMT.

The total number of tokens sold during the pre-sale period cannot exceed 60% of the total number of tokens initially put up for sale by the Main-Sale. If the number of requests received during the pre-sale period exceeds, request will be honored in the chronological order in line with the set limit, and excess orders will be returned to clients.

Team

	Moe Galal Chief Executive Officer / Founder Moe is a founder of SCI, and hopes to usher in the next generation of medicine using stem cells and other technological advancements relying on his 20+ years of experience in business.
	Ben Barel Chief Operations Officer / Co-Founder With more than twenty years of progressive corporate healthcare managing operations experience. Carrying demonstrated track record of driving margin improvement and operational efficiency.
	Ali Alrashidi Chief Technology Officer / Co-Founder A background rich in programming and development, Ali manages SCI’s blockchain platform. Ali’s support in furthering academic research in the field of blockchain will allow SCI to grow.
	Matt Galal Chief of Staff / Co-Founder Matt has over 15 years of experience as successful entrepreneur and is driven by success while taking a detail-oriented approach to everything he does.
	John Glavinovich, M.D. Medical Director With over 30 years’ experience in hospital-related clinical, management and operational practices, Dr. Glavinovich a non-traditional approach to the work being done by the team.

Roadmap

2013

Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.
Q4 2017

Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.
Advanced research begins to determine market and development opportunities.
Q1 2018

Attended Token 2049 conference in Hong Kong.
Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).
Attended CBC conference in San Francisco, CA.
Q2 2018

Attended ICO20 Summit in Santa Monica, CA.
Integration of smart contract technology is established.
Company headquarters incorporated in Gibraltar, GB.
Strategic efforts toward development begins.
Interviews with potential medical participants take place.
Q3 2018

Whitelist is scheduled to go live.
Token Sale starts.
Q4 2018

Token Sale ends and min max caps are assessed.
Distribution of Tokens to participants through ERC20 will commence.
Q1 2019

SCI will begin final testing and reporting based on blockchain technology being used.
Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.
Demo testing for SCI Application v 1.0 will begin.
Q2 2019

Release of the SCI Application v1.1
Enrollment begins for doctors, patients, and stem cell laboratories in the United States
Q3 2019

Release of Market Surveillance strategy for further growth
Release SCI Application v2.0
Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.
Announcement of first SCI Lab location and franchise expansion plan.
Q4 2019

Announcement of clinical development and research strategy in the stem cell field.
Public announcement regarding SCI achievements to date.
First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.
Q1 2020

Stem Cell Lab Evaluation report per first year of operation and development.
Release SCI earnings and financials report.
Release results of SCI's stem cell research and development to date.
Q2 2020

Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.
Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.
Q3 2020

Begin second phase of SCI stem cell research and development.
Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.
Q4 2020

Expansion and acquisition of SCI stem cell labs and clinics in Europe.
Q1 2021

Release SCI earnings and financials report for second year operation and development.
Release public update on SCI stem cell research and development.
Stem Cell Lab Evaluation report for second year.
Q2 2021

Release SCI Application v4.0 including:
A new platform for medical students, universities, and hospitals to engage with the SCI Application.
Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.

White Paper

Investment Info
Accepting	BTC, ETH, LTC, Fiat
Token Info
Country	Gibraltar
Hardcap	$36,000,000
Softcap	$3,000,000
Token	SCIA
Platform	Ethereum
Type	ERC20
Token Price	1 SCI = $0.15
Token Count	800,000,000
Schedule
Pre-Sale Start Date	2018-September-17
Pre-Sale End Date	2018-October-29
Crowd Sale Start Date	2018-November-21
Crowd Sale End Date	2019-January-17